J. F. Douglas

发表

J. F. Douglas, 1984 .

Oncogenicity Studies of Inhaled Methyl Tertiary‐butyl Ether (MTBE) in CD‐1 Mice and F‐344 Rats

J. F. Douglas, M. Bird, L. Andrews, 1997, Journal of applied toxicology : JAT.

Neurotoxicological Evaluation of Methyl Tertiary‐butyl Ether in Rats

J. F. Douglas, L. Andrews, J. Kneiss, 1997, Journal of applied toxicology : JAT.

Carcinogenicity testing of phthalate esters and related compounds by the National Toxicology Program and the National Cancer Institute.

J. F. Douglas, J. Huff, J. Haseman, 1982, Environmental health perspectives.

Thirteen-week subchronic toxicity studies of Direct Blue 6, Direct Black 38, and Direct Brown 95 dyes.

J. F. Douglas, J. Ward, J. Robens, 1980, Toxicology and applied pharmacology.

Chapter 16. Atherosclerosis

J. F. Douglas, J. Douglas, 1971 .

Carcinogenesis and Mutagenesis Testing

J. F. Douglas, J. Douglas, 2011, Contemporary Biomedicine.

Structure of the metabolite of carisoprodol, hydroxycarisoprodol.

J. F. Douglas, J. Edelson, A. Schlosser, 1965, Biochemical pharmacology.

Structures of the major metabolites of meprobamate.

L. S. Powell, J. F. Douglas, F. M. Berger, 1961, Journal of medicinal and pharmaceutical chemistry.

A new solvent system for the paper chromatographic separation of some pharmacologically active carbarnates

J. F. Douglas, A. Schlosser, J. Douglas, 1961 .

Gas chromatographic determination of meprobamate, 2-methyl-2-propyl-1,3-propanediol dicarbamate, in plasma and urine.

J. F. Douglas, N. B. Smith, T. Kelley, 1967, Analytical chemistry.

The carcinogenicity of dietary di(2-ethylhexyl) phthalate (DEHP) in Fischer 344 rats and B6C3F1 mice.

J. F. Douglas, J. Huff, J. Haseman, 1982, Journal of toxicology and environmental health.

Effect of concurrent administration of aspirin, indomethacin or hydrocortisone with gold sodium thiomalate against adjuvant-induced arthritis in the rat

J. F. Douglas, L. Knobloch, R. Duane Sofia, 1976, Agents and Actions.

Metabolic fate of benzyl N-benzyl carbethoxyhydroxamate (W-398).

J. F. Douglas, 1965, The Journal of pharmacology and experimental therapeutics.

Chlorphenesin metabolism in the rat and dog.

J. F. Douglas, J. Edelson, B. J. Ludwig, 1969, Biochemical pharmacology.

The prophylactic and therapeutic effects of gold sodium thiomalate against adjuvant-induced polyarthritis in rats

J. F. Douglas, R. Duane Sofia, J. Douglas, 1973, Agents and Actions.

Natural killer cells inviral arthritis

J. F. Douglas, P. Hertzog, J. Aaskov, 1987 .

Carcinogen Bioassay Design

J. F. Douglas, 1984 .

The metabolic fate of tybamate in the rat and dog.

J. F. Douglas, J. Edelson, B. J. Ludwig, 1966, Biochemical pharmacology.

INTERACTION OF PLASMA PROTEIN WITH RELATED 1,3-PROPANEDIOL DICARBAMATES.

J. F. Douglas, D. Powers, B. J. Ludwig, 1964, Biochemical pharmacology.

Studies on the Metabolism of Meprobamate

J. F. Douglas, N. Smith, B. J. Ludwig, 1963 .

Chapter 17. Atherosclerosis

J. F. Douglas, 1970 .

The effect of N-gamma-phenylpropyl-N-benzyloxy acetamide (W-1372) on experimental atherosclerosis and hypercholesteremia.

J. F. Douglas, S. Margolin, F. M. Berger, 1969, The Journal of pharmacology and experimental therapeutics.

Effect of N-γ-Phenylpropyl-N-benzyloxy Acetamide (W-1372) and of Clofibrate on the Lipids of Normal and Hypercholesteremia Rats

J. F. Douglas, G. Lu, F. M. Berger, 1969 .

Gas Chromatographic Determination of N-γ-Phenylpropyl-N-benzyloxy Acetamide (W-1372) in Blood

J. F. Douglas, J. A. Stockage, 1970 .

Metabolic Fate of N-γ-Phenylpropyl-N-benzyloxy Acetamide (W-1372) in Rats, Dogs, and Monkeys

J. F. Douglas, J. Edelson, B. J. Ludwig, 1970 .

Two-year inhalation toxicity study of propylene in F344/N rats and B6C3F1 mice.

J. F. Douglas, W. J. Clarke, J. Haseman, 1984, Toxicology and applied pharmacology.

Absorption, distribution, and metabolic fate of 7-chloro-3,3a-dihydro-2-methyl-2H,9H-isoxazolo-(3,2-b)(1,3)-benzoxazin-9-one in rats, dogs, and humans.

J. F. Douglas, E. Schuster, S. Shahinian, 1975, Journal of Pharmacy and Science.

Pharmacology of a new non-steroidal anti-inflammatory agent 7-chloro-3,3a-dihydro-2-methyl-2H,9H-isoxazolo-(3,2-b)(1,3)-benzoxazin-9-one (W-2395).

J. F. Douglas, R. Sofia, R. Gordon, 1974, European journal of pharmacology.

Seclazone: biotransformation during absorption in the rat, binding in plasma, and disappearance from plasma in the dog.

J. F. Douglas, J. Edelson, B. J. Ludwig, 1973, Drug metabolism and disposition: the biological fate of chemicals.

Absorption, distribution, and metabolic fate of seclazone (7-chloro-3,3a-dihydro-2H,9H-isoxazolo(3,2-b) (1,3)benzoxazin-9-one).

J. F. Douglas, J. Edelson, B. J. Ludwig, 1973, Journal of pharmaceutical sciences.

Neurotoxicological Evaluation of Methyl Tertiary‐butyl Ether in Rats

J. F. Douglas, L. S. Andrews, L. Andrews, 1997, Journal of applied toxicology : JAT.

Developmental Toxicity Evaluation of Methyl Tertiary-butyl Ether (MTBE) by Inhalation in Mice and Rabbits

J. F. Douglas, R. Tyl, L. Andrews, 1997 .

Oncogenicity Studies of Inhaled Methyl Tertiary‐butyl Ether (MTBE) in CD‐1 Mice and F‐344 Rats

J. F. Douglas, M. Bird, L. S. Andrews, 1997, Journal of applied toxicology : JAT.

Assessment of the In Vivo Mutagenic Potential of Methyl Tertiary‐butyl Ether

J. F. Douglas, R. H. Mckee, J. Galvin, 1997, Journal of applied toxicology : JAT.

Evaluation of 13‐Week Inhalation Toxicity Study on Methyl t‐Butyl Ether (MTBE) in Fischer 344 Rats

J. F. Douglas, D. Dodd, L. S. Andrews, 1997, Journal of applied toxicology : JAT.